Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07021742 · ClinicalTrials.gov registry record
BioHealx® Anal Fistula Device Post Market Surveillance Study
A clinical trial of Fistula-in-ano, sponsored by Signum Surgical USA.
- Recruiting
- Registry status
- 50
- Enrollment target
- 2
- Study locations
NCT07021742 is a study of Fistula-in-ano that is actively recruiting participants, run by Signum Surgical USA. The registered enrollment target is 50 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT07021742, a study of Fistula-in-ano, is actively recruiting participants, sponsored by Signum Surgical USA.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
This post market surveillance study is a single arm multicenter study to demonstrate the long-term durability and effectiveness of the BioHealx Anal Fistula Device for fistula-in-ano closure (internal and external fistula openings).
Conditions Studied
Interventions
- DEVICE BioHealx
Study Locations (2)
Florida
- The Colorectal Institute - Fort Myers
Pennsylvania
- Maininle Health Lankenau - Bryn Mawr
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-06-14 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07021742
The ClinicalTrials.gov registry entry for NCT07021742 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Signum Surgical USA, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fistula-in-ano appearing as the primary indexed condition, and to 1 intervention - of which BioHealx is the first listed.
NCT07021742 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07021742 about?
NCT07021742 is a clinical study titled "BioHealx® Anal Fistula Device Post Market Surveillance Study". This post market surveillance study is a single arm multicenter study to demonstrate the long-term durability and effectiveness of the BioHealx Anal Fistula Device for fistula-in-ano closure (internal and external fistula openings).
What is the current status of trial NCT07021742?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-06-14. Estimated completion is 2026-12.
What conditions does trial NCT07021742 study?
This clinical trial studies the following conditions: Fistula-in-ano.
What interventions are being tested in trial NCT07021742?
The interventions under investigation include: BioHealx (DEVICE).
Who is sponsoring clinical trial NCT07021742?
This trial is sponsored by Signum Surgical USA, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07021742 being conducted?
This trial has 2 study locations across Florida, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fistula-in-ano
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.